Synapse - Works

Results (82)

Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation

Journal Article

Elkrief, A.; Waters, N. R.; Smith, N.; Dai, A.; Slingerland, J.; Aleynick, N.; Febles, B.; Gogia, P.; Socci, N. D.; Lumish, M.; more...
Cancer Immunology Research (2024)

Fulltext@MSK | Save

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma

Journal Article

Li, Z.; Zhuang, X.; Pan, C. H.; Yan, Y.; Thummalapalli, R.; Hallin, J.; Torborg, S.; Singhal, A.; Chang, J. C.; Manchado, E.; more...
Cancer Discovery (2024)

Fulltext@MSK | Save

Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer

Journal Article

Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

De novo and histologically transformed small-cell lung cancer is sensitive to lurbinectedin treatment through the modulation of EMT and NOTCH signaling pathways

Journal Article

Chakraborty, S.; Coleman, C.; Manoj, P.; Demircioglu, D.; Shah, N.; de Stanchina, E.; Rudin, C. M.; Hasson, D.; Sen, T.
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN

Meeting Abstract

Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; Stewart, R.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Profiling of the circulating cell-free DNA methylome for detection and subtyping of small cell lung cancers

Meeting Abstract

Rothwell, D. G.; Chemi, F.; Pearce, S.; Clipson, A.; Hill, S.; Conway, A. M.; Richardson, S.; Murat, K.; Caeser, R.; Egger, J.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma

Meeting Abstract

Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
Cancer Research (2022)

Fulltext@MSK | Save

Ferroptosis evasion as a therapeutic strategy in STK11/KEAP1 co-mutant lung adenocarcinoma

Meeting Abstract

Durani, V.; Wohlhieter, C. A.; Quintanal-Villalonga, A.; Sen, T.; Manoj, P.; Rudin, C. M.
Cancer Research (2022)

Fulltext@MSK | Save

STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC

Meeting Abstract

Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
Cancer Research (2022)

Fulltext@MSK | Save

A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response

Meeting Abstract

Rosen, M.; Amar, D.; Winters, I.; Rizvi, H.; Nie, W.; Wall, G.; Petrov, D.; Winslow, M.; Rudin, C.; Juan, J.
Cancer Research (2022)

Fulltext@MSK | Save